FDA launches new office in CDER to modernize clinical trials

The FDA announced the creation of a new office within its Center for Drug Evaluation and Research (CDER) dedicated to modernizing clinical trials.

The office aims to accelerate the design and execution of trials, addressing the agency’s priority to speed the development of new therapies.

Officials said the initiative will coordinate efforts across the agency and work with industry stakeholders to implement new tools and processes, though details on staffing and timeline were not provided.